BSEBoard Meeting4d ago · 5 Nov 2026, 06:50 pm

Dear Sir/Madam Please refer to our earlier letter dated 28.10. 2026, wherein we have intimated the convening of our board meeting on Thursday November 5th'',2026 for consideration and approval of the Unaudited Standalone and Consolidated Financial results, Statement of Assets and Liabilities and Cash Flow statement of the Company for the Quarter ended September 30, 2026 and other allied matters. In this regard, please be informed that the Meeting ....

Crestchem Ltd · 526269

✦ AI SummaryResults

Crestchem Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended September 30, 2026, and has approved and taken on record the same. The board meeting was held on November 5, 2026, and the company has also submitted a limited review report on the financial results.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Crestchem Ltd - 526269 - Board Meeting Outcome for Unaudited Standalone And Consolidated Financial Results, Statement Of Assets And Liabilities And Cash Flow Statement For The Quarter Ended September 30, 2026 Regulation 30 & 33 And Part A Of Schedule Ill Of The SEBI (LODR) Regulations, 2015

Attachments (1)

📄

5e1a374a-1fbb-434b-b080-c84974c0e2e3.pdf

pdf

Download →
View document text
CRESTCHEM LIMITED Corporate Office:303B, Central Business Space, Opp: Fortune Land Mark Hotel, Opp: HDFC Bank, Near Usamanpura Cross Road, Ashram Road, Anmedabad-380013. Phone: +91-9409119484, Email: info @crestchemlimited.in GST Number : 24AAACC8722C1Z5 CIN NO. L24100GJ1991PLC015530 WEBSITE: www.crestchemlimited.in Date: November 5%, 2026 BSE Limited, Dept of Corporate Services, Phiroze Jeejeebhoy Towers, 25th Floor,Dalal Street, Mumbai-400001 Scrip Code: 526269 Subject: Reference: Outcome of Board Meeting, Submission of Unaudited Standalone and Consolidated Financial results, Statement of Assets and Liabilities and Cash Flow statement for the Quarter ended September 30, 2026 Regulation 30 & 33 and Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam Please refer to our earlier letter dated Wednesday October 28,2026, wherein we have intimated the convening of our board meeting on Thursday November 5t',2026 for consideration and approval of the Unaudited Standalone and Consolidated Financial results, Statement of Assets and Liabilities and Cash Flow statement of the Company for the Quarter and Half year ended September 30, 2026 and other allied matters. In this regard, please be informed that the Meeting of the Board of Directors of the Company was held today at 3:40 p.m. (Noon) and the Board of Directors have, inter-alia, approved and taken on record the following: Approved and taken on record Unaudited Standalone and Consolidated Financial Results along with the Statement of Assets and Liabilities and Cash Flow statement of the Company under Ind AS for the Quarter and Half year ended September 30, 2026 and Limited Review Report thereon in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board meeting concluded with a vote of thanks to the Chair at 4:20PM. You are requested to take the same on record. For CRESTCHEM LIMITED, BAGGA Digitally signed by BAGGA INDRAJYOTSINGH RANJITSINGH INDRAJYOTSINGH Date: 2026.11.05 18:42:08 RANJITSINGH +05'30" Indrajyot Singh Bagga Compliance Officer and Asst. Company Secretary (ACS-81745) Encl: Unaudited Standalone and Consolidated Financial Results, Statement of Asset and Liabilities and Cash flow statement of the Company under Ind AS for the Quarter ended September 30, 2026 and Limited Review Report thereon Reg. office: Sr. No. 550/1, Sub Plot o. 12, Village Indrad, Taluka -Kadi, District- Mehsana, Pin code-382715, Gujarat SAMIR M. SHAH & ASSOCIATES Chartered Accountants “Heaven”, 8, Western Park Society, Nr. TRP Mall, Bopal, Ahmedabad – 380058 Phone : +91- 76220 12032 E-mail : samir@smshah.co.in -------------------------------------------------------------------------------------------------------------------------------------- Limited Review Report on Consolidated Un-Audited Quarterly and Year-to-Date Financial Results of Crestchem Limited under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 To the Board of Directors of Crestchem Limited Ahmedabad 1. We have reviewed the accompanying Statement of Consolidated Un-Audited Financial Results of Crestchem Limited (‘the Parent") and its subsidiaries (the Parent and its subsidiaries together referred to as "the Group") for the Quarter Ended September 30, 2026 and Year-to-Date Results for the period from April 01, 2026 to September 30, 2026 (‘the Statement’), being submitted by the Parent pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('Listing Regulations') 2. Management’s Responsibility for the statement This Statement, which is the responsibility of the Parent's management and approved by the Parent's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in lndian Accounting Standard 34 "Interim Financial Reporting" ("lnd AS 34"), prescribed under Section 133 of the Companies Act, 2013, and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the Statement based on our review. 3. Auditor’s Responsibility We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity", issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. We also performed procedures in accordance with the circular issued by the SEBI under Regulation 33 (B) of the Listing Regulations, to the extent applicable. The Statement includes the results of the following entities: Holding Company: Crestchem Limited Subsidiary Company: Oleo Biosciences Private Limited 5. Based on our review conducted and procedures performed as stated in paragraph 4, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. The consolidated unaudited financial results include the unaudited financial results of subsidiary, whose interim financial information reflects total revenues of Rs. Nil, total net loss after tax of Rs. 8.01 Lakhs, for the quarter ended September 30, 2026 as considered in the consolidated unaudited financial results. These interim financial statements of the subsidiary included have been prepared by the Management which have been unaudited and furnished to us by the Management and our conclusion on these interim financial statements, in so far as it relates to the amounts and disclosures included in respect of the subsidiary, is based solely on the information and explanations given to us by the Management. Our conclusion on the statement in respect of matters stated in para 6 above is not modified. Place : AHMEDABAD For SAMIR M. SHAH & ASSOCIATES Date : NOVEMEBER 05, 2026 CHARTERED ACCOUNTANTS FIRM REG. No.: 122377W SAMIR M. SHAH (PARTNER) MEMBERSHIP No.: 111052 UDIN: 26111052SIHUKE6033 SAMIR M. SHAH & ASSOCIATES Chartered Accountants “Heaven”, 8, Western Park Society, Nr. TRP Mall, Bopal, Ahmedabad — 380058 Phone : +91- 76220 12032 E-mail : samir@smshah.co.in Limited Review Report on unaudited quarterly standalone financial results and year-to-date results of Crestchem Limited pursuant to the Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015. Board of Directors of Crestchem Limited Ahmedabad 1. We have reviewed the accompanying statement of unaudited standalone financial results of Crestchem Limited ("the Company") for the quarter ended September 30, 2026 and year to date from April 01, 2026 to September 30, 2026 (the ‘Statement'} attached herewith, being submitted by the Company pursuant to the requirements Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended. Management’s Responsibility for the statement This Statement, which is the responsibility of the Company's Management and approved by the Company's Board of Directors, has been prepared in accordance with the recognition and mea [Showing first 8,000 characters — download PDF for full document]